| Literature DB >> 27766263 |
Stavros Sfoungaristos1, Ioannis Mykoniatis2, Ayman Isid1, Ofer N Gofrit1, Shilo Rosenberg1, Guy Hidas1, Ezekiel H Landau1, Dov Pode1, Mordechai Duvdevani1.
Abstract
Objective. To evaluate and compare the efficacy and safety of retrograde versus antegrade ureteroscopic lithotripsy for the treatment of large proximal ureteral stones. Patients and Methods. We retrospectively analyzed the medical records of patients with proximal ureteral stones >15 mm, treated in our institution from January 2011 to January 2016. Intraoperative parameters, postoperative outcomes, and complications were recorded and compared between the two techniques. Results. Our analysis included 57 patients. Thirty-four patients (59.6%) underwent retrograde and 23 patients (40.4%) underwent antegrade ureteroscopy. There was no significant difference in patients' demographics and stone characteristics between the groups. Stone-free rate was significantly higher (p = 0.033) in the antegrade group (100%) compared to retrograde one (82.4%). Fluoroscopy time, procedure duration, and length of hospitalization were significantly (p < 0.001) lower in retrograde approach. On the other hand, the need for postoperative stenting was significantly lower in the antegrade group (p < 0.001). No difference was found between the groups (p = 0.745) regarding postoperative complications. Conclusions. Antegrade ureteroscopy is an efficient and safe option for the management of large proximal ureteral stones. It may achieve high stone-free rates compared to retrograde ureteroscopy with the drawback of longer operative time, fluoroscopy time, and length of hospitalization.Entities:
Mesh:
Year: 2016 PMID: 27766263 PMCID: PMC5059524 DOI: 10.1155/2016/6521461
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Patients' demographics and clinical data.
| Antegrade | Retrograde |
| |
|
| |||
| Number of patients | 23 (40.4) | 34 (59.6) | |
|
| |||
| Male | 17 (73.9) | 26 (76.5) | 0.826† |
| Female | 6 (26.1) | 8 (23.5) | |
|
| 51.2 ± 13.6 | 51.0 ± 17.5 | 0.916‡ |
|
| 27.8 ± 3.49 | 27.3 ± 4.92 | 0.386‡ |
|
| |||
| Right | 12 (52.2) | 16 (47.1) | 0.705† |
| Left | 11 (47.8) | 18 (52.9) | |
|
| 21.4 ± 4.87 | 19.2 ± 2.22 | 0.241‡ |
|
| 219.4 ± 61.8 | 215.9 ± 36.0 | 0.733‡ |
|
| 1069.2 ± 285.6 | 1020.7 ± 299.9 | 0.649‡ |
|
| |||
| No | 15 (65.2) | 26 (76.5) | 0.354† |
| Yes | 8 (34.8) | 8 (23.5) | |
|
| |||
| <grade 2 | 6 (26.1) | 9 (26.5) | 0.974† |
| ≥grade 2 | 17 (73.9) | 25 (73.5) | |
†Chi-square χ 2 test, ‡Mann-Whitney U test, and sd = standard deviation.
Intraoperative parameters and postoperative outcomes.
| Antegrade | Retrograde |
| |
|---|---|---|---|
|
| 63.2 ± 12.0 | 35.3 ± 16.0 | <0.001‡ |
|
| 172.7 ± 50.6 | 45.6 ± 39.4 | <0.001‡ |
|
| |||
| No | 19 (82.6) | 9 (26.5) | <0.001† |
| Yes | 4 (17.4) | 25 (73.5) | |
|
| 4.00 ± 1.83 | 1.65 ± 1.48 | <0.001‡ |
|
| |||
| No | 17 (73.9) | 27 (79.4) | 0.627† |
| Yes | 6 (26.1) | 7 (20.6) | |
|
| |||
| Grade 0 | 17 (73.9) | 28 (82.4) | 0.745† |
| Grade 1 | 3 (13.0) | 3 (8.8) | |
| Grade 2 | 3 (13.0) | 3 (8.8) | |
|
| |||
| No | 0 (0.0) | 6 (17.6) | 0.033† |
| Yes | 23 (100.0) | 28 (82.4) |
Statistically significant, †Chi-square χ 2 test, ‡Mann-Whitney U test, and sd = standard deviation.